Product Images Motegrity

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Motegrity NDC 54092-547 by Takeda Pharmaceuticals America, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - motegrity 01

Chemical Structure - motegrity 01

PRINCIPAL DISPLAY PANEL - 1 mg Tablet Bottle Label - motegrity 02

PRINCIPAL DISPLAY PANEL - 1 mg Tablet Bottle Label - motegrity 02

This is a description for a medication called "Motegrity". The medication comes in a tablet form and each tablet contains a certain amount of active ingredient. The tablets should be stored at a controlled room temperature, between 20°C and 25°C, and should be kept out of reach of children in their original container. The recommended dose is one tablet per day. The text also includes information about the manufacturer, such as their trademarked logos.*

PRINCIPAL DISPLAY PANEL - 2 mg Tablet Bottle Carton - motegrity 03

PRINCIPAL DISPLAY PANEL - 2 mg Tablet Bottle Carton - motegrity 03

Mategrity® is a medication in the form of tablets which contain prucalopride (2mg) and are stored at a temperature between 20-25°C. The tablets should be kept in their original container to protect them from moisture, and kept out of reach of children. This medication is distributed by Takeda Pharmaceuticals in America, and the recommended dose is one tablet per day. This text is related to instructions for storing and administering Mategrity® tablets.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.